Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
UBE2D1	"E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A"	ENSG00000072401	"Ubiquitin conjugating enzyme E2 D1"	P51668	10	58334975-58370753	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 74.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 41.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (8.04e-6)"	"unprognostic (9.71e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.66e-2)"	8.2	10.6	8.1	10.0	7.9	17.1	7.5	7.7	9.0	6.3	7.3	5.5	4.8	4.7	8.5	5.5	8.2	5.5	6.4	25.6	7.6	7.2	5.5	5.4	7.0	13.7	8.1	6.7	5.9	4.8	5.3	7.4	6.8	7.4	6.5	7.9	3.5	6.4	5.0	74.9	4.6	5.8	8.8	8.4	11.0	5.6	3.2	8.4	5.5	6.0	25.1	7.1	9.5	10.0	3.7	7.2	41.0	13.7	2.8	3.5	7.1	10.6	5.8	10.8	13.9	22.2	17.9	7.0	7.0	12.0	8.1	11.9	11.7	9.2	0.0	11.1	10.5	9.7	20.9	10.2	11.4	11.0	12.3	2.8	2.1	6.7	14.6	8.4	6.8	20.7	11.5	8.4	15.7	16.1	5.5	4.5	10.9	3.3	9.0	9.4	13.2	9.1	7.6	9.8	5.9	12.1	6.2	8.2	11.0	13.8	23.3	11.2	8.5	5.7	12.9	3.1	10.9	10.6	7.7	11.5	8.9	9.4	9.8	17.5	3.5	2.8	13.7	6.2	2.4	9.5	2.8	3.3	2.9	3.0	7.2	3.7	3.0	2.3	41.0	2.8	7.9	3.0	3.5	7.1	8.1	7.9	7.7	9.0	7.6	7.2	8.1	6.7	7.4	8.4
UBE2J2	"NCUBE2, Ubc6p"	ENSG00000160087	"Ubiquitin conjugating enzyme E2 J2"	Q8N2K1	1	1253909-1273885	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway, Unfolded protein response"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (2.09e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.46e-2)"	24.4	22.2	17.5	21.6	17.1	19.4	33.0	23.8	24.9	17.8	22.0	17.9	19.9	22.0	22.9	21.4	25.2	21.8	20.7	21.2	17.5	17.1	21.6	27.3	17.4	27.4	15.9	15.4	19.4	36.3	14.4	22.8	22.6	15.9	16.9	16.2	18.7	24.2	20.2	29.8	23.2	23.6	19.3	13.1	25.2	22.2	68.3	12.8	26.1	22.8	21.7	23.8	18.3	19.3	24.5	22.3	39.6	23.0	22.0	25.3	17.7	25.2	10.5	15.0	14.4	12.2	12.5	11.7	19.6	15.5	26.8	19.6	18.7	18.5	13.6	20.9	18.0	18.5	15.2	19.5	21.3	23.1	27.3	20.5	20.6	16.8	23.7	18.8	19.7	11.7	10.9	21.0	15.6	18.8	28.3	13.5	15.5	12.6	27.2	21.1	16.2	26.4	25.4	14.0	22.5	13.9	8.6	55.5	27.4	13.5	29.1	30.9	14.9	21.4	15.3	16.2	15.6	18.7	20.0	29.9	29.0	38.1	20.9	29.9	12.8	38.2	23.0	39.6	22.0	22.2	20.1	24.5	23.4	22.8	22.3	21.7	21.2	20.9	32.6	22.0	21.3	20.8	25.3	17.7	17.5	17.1	23.8	24.9	17.5	17.1	15.9	15.4	15.9	12.8
UBE2C	UBCH10	ENSG00000175063	"Ubiquitin conjugating enzyme E2 C"	O00762	20	45812576-45816957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 130.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"CAB011464, HPA034569, CAB035990, HPA054975"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB011464: AB_442965, CAB035990: , HPA034569: , HPA054975: "	"unprognostic (1.45e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (6.24e-6)"	"unprognostic (2.27e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (6.91e-4)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.09e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.68e-1)"	3.1	2.3	0.4	24.0	0.9	25.1	4.3	0.4	0.7	3.8	9.5	0.4	0.8	7.8	2.0	2.6	25.6	0.6	3.2	2.8	0.5	0.4	2.1	2.1	4.6	15.6	0.6	0.5	1.2	1.3	0.0	0.6	12.6	0.9	1.3	11.7	0.7	3.7	0.6	1.0	8.3	10.0	3.5	1.2	11.6	7.0	15.3	0.5	130.8	0.8	17.6	26.3	2.8	7.8	1.2	0.9	2.7	0.6	2.4	10.0	4.2	39.2	28.8	52.0	24.9	1.4	3.2	29.9	31.2	15.8	51.4	36.9	94.6	45.4	41.6	30.6	14.8	38.8	0.2	33.4	52.5	17.7	27.4	12.8	22.1	24.8	0.4	18.3	32.2	1.0	3.6	34.8	34.1	25.0	0.2	35.4	42.3	64.6	30.2	5.2	31.2	69.0	32.1	47.1	0.2	17.3	13.6	30.0	25.0	49.1	36.0	19.7	36.3	27.0	9.1	46.1	40.3	31.3	60.3	11.2	0.3	46.4	28.0	13.1	43.7	0.0	0.1	0.0	0.2	0.0	0.0	1.2	1.2	2.3	0.9	0.2	0.2	0.1	2.7	2.4	0.6	0.5	10.0	4.2	0.4	0.9	0.4	0.7	0.5	0.4	0.6	0.5	0.9	0.5
UBE2G1	"UBC7, UBE2G"	ENSG00000132388	"Ubiquitin conjugating enzyme E2 G1"	P62253	17	4269259-4366628	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045681, HPA050551"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA045681: , HPA050551: "	"unprognostic (1.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.80e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.50e-2)"	10.8	11.1	12.6	17.8	13.5	14.3	11.2	11.6	15.3	13.0	19.4	17.8	8.9	11.9	13.3	8.5	27.4	9.2	9.7	26.9	13.5	11.2	14.6	17.7	8.9	18.7	15.2	9.7	9.1	17.1	12.0	6.0	11.4	14.5	14.0	13.3	8.8	11.9	12.0	95.6	14.1	16.6	14.6	19.4	15.0	11.9	11.8	13.6	21.3	12.5	20.7	23.3	17.7	16.5	23.7	13.1	24.4	11.5	20.5	20.6	13.1	21.2	23.0	21.5	15.7	17.6	18.7	30.7	20.7	16.7	19.8	17.4	15.8	10.9	33.3	21.8	20.3	23.0	26.7	19.2	31.9	17.5	21.8	12.4	12.2	18.0	17.3	18.0	23.6	15.9	28.8	18.7	27.3	26.4	21.8	36.1	16.2	9.5	22.9	16.6	23.7	12.0	29.8	11.4	30.4	23.0	14.0	9.3	17.4	19.5	17.0	16.1	16.7	11.8	19.8	19.9	15.2	23.2	23.1	14.0	16.4	47.1	15.3	16.9	15.2	8.1	10.3	24.4	15.4	10.8	20.6	23.7	20.1	20.1	13.1	15.5	20.2	20.5	18.6	20.5	11.5	9.6	18.3	13.1	12.6	13.5	11.6	15.3	13.5	11.2	15.2	9.7	14.5	13.6
UBE2V2	"DDVit-1, DDVIT1, EDAF-1, EDPF-1, EDPF1, MMS2, UEV-2, UEV2"	ENSG00000169139	"Ubiquitin conjugating enzyme E2 V2"	Q15819	8	48008400-48064708	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052535, HPA053186"			Supported	Nucleoplasm			1500000	Nucleoplasm		"HPA052535: , HPA053186: "	"unprognostic (3.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavourable (4.96e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.62e-2)"	22.4	28.3	38.8	19.3	34.5	12.5	23.1	28.3	51.1	17.9	22.8	13.8	12.9	22.0	21.7	17.8	31.8	15.3	17.7	14.6	40.5	41.7	22.7	37.8	14.6	22.5	40.1	43.4	16.5	12.3	19.2	36.4	21.4	48.5	22.5	23.7	13.0	13.8	21.0	29.3	15.9	20.4	24.6	26.7	14.3	19.0	20.5	20.6	20.8	24.0	18.5	24.1	25.0	17.2	37.9	42.2	34.6	40.1	51.7	49.4	42.8	31.2	18.2	40.7	22.5	22.4	25.2	14.4	32.8	23.1	33.2	29.2	22.9	24.5	38.5	19.3	31.3	18.9	36.9	30.7	44.8	13.1	25.9	34.6	22.3	19.1	28.1	18.8	10.4	23.7	32.1	26.7	42.8	28.0	42.2	24.0	41.9	23.9	59.9	36.6	37.7	12.1	30.1	18.0	18.9	35.4	25.4	44.7	29.2	27.6	24.6	28.9	41.3	25.2	15.4	28.2	25.8	25.2	30.4	24.0	40.7	48.3	36.6	33.3	29.9	30.6	35.9	34.6	31.0	40.1	37.0	37.9	38.8	37.8	42.2	32.8	39.1	43.8	22.3	51.7	38.2	35.1	49.4	42.8	38.8	34.5	28.3	51.1	40.5	41.7	40.1	43.4	48.5	20.6
UBE2V1	"CROC-1, CROC1, UBE2V, UEV-1, UEV1A"	ENSG00000244687	"Ubiquitin conjugating enzyme E2 V1"	Q13404	20	50081124-50115959	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA052535, HPA053186"			Enhanced	Nucleoplasm			4000000	Nucleoplasm		"HPA052535: , HPA053186: "	"unprognostic (1.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (4.58e-5)"	"unprognostic (2.58e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-1)"	35.2	35.3	44.9	31.7	52.4	25.6	29.7	36.9	61.7	27.4	37.7	33.8	19.3	34.2	29.1	32.7	43.6	27.4	28.7	38.1	37.5	39.3	39.2	61.8	34.1	36.8	36.4	33.3	37.2	60.8	36.7	23.2	45.9	44.7	30.3	37.3	38.7	38.6	35.0	46.0	37.8	40.1	43.7	29.0	40.2	33.3	23.2	23.2	35.0	30.2	32.0	50.7	49.0	31.7	37.4	40.1	33.9	39.1	54.2	57.4	70.2	29.2	18.3	34.6	20.6	28.4	49.0	19.2	33.3	32.9	71.0	34.2	91.3	22.1	28.5	30.9	43.1	25.9	25.3	45.7	61.9	19.9	15.9	27.9	13.7	40.4	25.6	33.9	22.6	39.0	27.6	34.9	23.3	47.8	34.7	17.4	39.6	19.7	30.5	26.9	24.1	32.4	16.9	39.5	26.0	49.0	21.1	20.3	24.5	33.9	59.3	25.1	22.7	30.8	41.5	39.4	36.5	33.3	26.8	17.3	22.2	23.1	42.9	17.7	27.2	25.5	39.1	33.9	56.6	38.5	57.4	37.4	47.0	53.9	40.1	31.0	48.3	52.4	13.8	54.2	33.0	31.6	44.4	70.2	44.9	52.4	36.9	61.7	37.5	39.3	36.4	33.3	44.7	23.2
UBE2E1	UbcH6	ENSG00000170142	"Ubiquitin conjugating enzyme E2 E1"	P51965	3	23805903-23891316	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030445, CAB073413"	Approved		Approved	Nucleoplasm				Nucleoplasm		"CAB073413: , HPA030445: AB_10669599"	"unprognostic (7.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.91e-3)"	"unprognostic (7.13e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (9.97e-7)"	"unprognostic (3.69e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	32.0	28.1	50.8	34.7	44.4	56.1	52.6	38.7	43.4	41.9	40.6	32.4	27.5	23.9	35.3	35.6	57.9	29.5	29.9	58.5	47.3	43.2	33.6	34.0	34.9	44.9	52.0	36.9	36.5	32.0	41.6	22.5	44.5	38.1	38.5	37.8	23.2	30.3	36.4	52.2	33.3	25.8	44.1	55.6	36.3	29.9	24.3	43.3	33.8	41.4	38.0	47.3	52.2	46.3	6.7	7.6	6.8	9.1	7.0	7.2	4.1	33.3	21.0	33.2	16.5	20.3	29.6	29.0	25.3	39.3	28.4	38.1	15.8	37.0	29.5	21.4	24.3	10.8	39.1	31.2	37.3	35.7	43.7	40.8	15.8	19.3	29.2	40.2	21.8	27.9	29.5	36.2	48.7	45.1	28.5	33.0	22.7	17.2	28.2	43.7	48.7	53.9	31.4	14.5	85.0	44.2	23.8	9.6	34.5	22.6	21.0	36.4	23.6	53.2	29.3	20.9	25.9	15.4	18.7	27.5	16.3	58.5	22.5	38.6	16.1	2.4	8.4	6.8	4.5	9.1	6.5	6.5	5.4	3.8	7.3	6.7	7.2	4.3	3.3	7.0	5.8	7.6	3.9	4.1	50.8	44.4	38.7	43.4	47.3	43.2	52.0	36.9	38.1	43.3
UBE2S	E2-EPF	ENSG00000108106	"Ubiquitin conjugating enzyme E2 S"	Q16763	19	55399745-55407777	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.0;lymphoid tissue: 60.2;testis: 69.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015228, HPA057150"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB015228: , HPA057150: "	"unprognostic (2.79e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (8.00e-6)"	"unprognostic (1.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.08e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavourable (8.16e-8)"	"unprognostic (1.05e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	10.2	9.2	18.0	19.5	15.9	68.0	4.7	11.4	21.6	6.1	12.0	9.1	4.5	8.4	7.1	7.2	17.1	6.0	9.7	18.0	18.7	18.1	5.9	5.6	6.3	22.9	13.7	14.4	6.4	6.0	3.7	12.9	9.8	12.9	7.0	7.1	6.2	4.9	5.3	7.3	6.2	7.3	10.7	15.3	11.0	10.6	69.4	8.2	60.2	5.9	14.3	21.1	10.0	7.1	4.5	3.1	6.0	1.9	0.6	2.6	0.3	59.4	32.2	28.3	22.6	1.8	2.6	5.0	48.4	14.7	29.9	27.3	21.8	21.3	57.9	20.1	12.1	17.5	28.4	12.6	13.3	45.3	94.2	34.6	18.5	7.0	5.4	41.3	33.7	2.8	3.5	22.0	21.3	11.7	34.3	40.6	18.7	15.7	56.0	21.5	71.1	54.7	49.3	21.8	20.8	8.0	12.7	72.0	39.0	61.7	15.3	27.4	10.9	22.5	17.9	18.1	51.3	15.3	115.2	32.7	78.5	67.9	18.9	29.3	65.3	1.1	1.9	2.9	1.8	1.5	1.2	4.5	2.6	2.6	1.5	1.6	2.5	1.5	6.0	0.6	0.9	3.1	1.0	0.3	18.0	15.9	11.4	21.6	18.7	18.1	13.7	14.4	12.9	8.2
UBE2O	E2-230K	ENSG00000175931	"Ubiquitin conjugating enzyme E2 O"	Q9C0C9	17	76389451-76453206	"Enzymes, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023605	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"			1600000	Nucleoplasm	"Nuclear bodies"	"HPA023605: "	"unprognostic (8.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (6.84e-8)"	"unprognostic (3.54e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavourable (4.34e-9)"	"unprognostic (7.22e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	8.5	8.5	13.8	10.2	22.6	19.2	7.3	25.2	38.1	9.4	7.2	12.2	7.4	9.9	9.9	8.2	11.7	10.8	7.1	15.4	12.7	15.2	6.5	7.6	6.6	12.8	11.7	14.6	13.9	14.4	16.4	14.3	9.8	30.6	9.4	6.0	10.5	13.4	10.4	23.0	15.2	8.2	8.0	8.0	10.8	10.8	18.1	12.2	10.9	15.8	6.9	9.2	8.6	9.1	4.9	4.1	2.7	1.7	1.5	4.0	1.9	12.9	14.9	15.2	18.7	9.6	6.1	13.2	6.1	6.6	9.9	9.7	12.9	6.6	18.4	4.3	7.5	13.1	17.7	10.5	7.1	5.2	21.8	18.6	9.7	21.6	7.9	11.2	11.3	6.2	8.6	9.5	8.2	13.4	15.5	16.4	5.0	10.7	22.2	13.0	14.1	20.0	22.0	19.6	20.2	4.4	11.1	22.6	20.3	8.9	23.2	12.2	13.3	8.1	7.9	11.7	11.0	9.9	10.0	13.6	4.4	15.5	12.8	9.4	7.6	0.0	1.7	2.7	4.0	0.8	2.2	2.6	2.6	2.0	1.0	4.9	2.1	3.0	0.4	1.5	1.0	4.1	2.3	1.9	13.8	22.6	25.2	38.1	12.7	15.2	11.7	14.6	30.6	12.2
UBE2Q1	"NICE-5, PRO3094, UBE2Q"	ENSG00000160714	"Ubiquitin conjugating enzyme E2 Q1"	Q7Z7E8	1	154548577-154559028	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063368	Approved		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA063368: "	"unprognostic (3.88e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.64e-3)"	"unprognostic (5.32e-3)"	"unprognostic (6.10e-3)"	"prognostic unfavourable (8.74e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (4.84e-7)"	"unprognostic (2.20e-1)"	"unprognostic (4.46e-1)"	"prognostic favourable (1.86e-5)"	"unprognostic (1.04e-2)"	17.3	18.7	26.5	16.2	29.4	24.2	19.4	26.4	29.0	20.0	21.2	18.7	8.2	16.2	18.3	25.4	20.9	21.8	18.2	17.6	24.5	25.8	25.7	27.4	23.0	26.3	22.8	21.0	21.7	27.2	21.4	29.3	24.5	27.2	21.4	25.7	18.5	19.0	19.8	19.1	21.6	21.4	21.9	19.1	26.0	20.5	30.0	22.0	25.1	21.0	14.0	29.9	19.3	18.5	3.2	5.1	8.1	3.1	4.7	6.2	1.6	18.0	15.7	22.2	16.9	22.8	23.6	19.2	17.9	27.4	23.2	18.8	17.6	19.4	22.3	25.9	25.0	15.8	26.1	20.8	20.0	22.4	16.5	17.7	14.0	17.0	28.8	28.7	28.5	22.7	27.6	18.7	21.7	29.7	14.8	27.7	29.5	28.0	17.5	21.1	30.3	26.7	20.2	15.5	23.4	25.4	19.3	22.6	31.6	18.2	34.3	29.4	20.9	43.8	20.6	15.0	16.8	17.7	19.1	33.8	25.0	29.5	16.8	20.3	22.7	8.1	2.8	5.6	4.8	3.1	4.3	3.0	4.5	5.9	2.5	3.2	5.0	5.7	4.4	4.7	2.6	5.1	6.2	1.6	26.5	29.4	26.4	29.0	24.5	25.8	22.8	21.0	27.2	22.0
UBE2F	NCE2	ENSG00000184182	"Ubiquitin conjugating enzyme E2 F (putative)"	Q969M7	2	237966827-238042782	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA037444	Approved		Approved	Cytosol				Cytosol		"HPA037444: AB_10672491"	"unprognostic (1.73e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (2.72e-4)"	"unprognostic (3.43e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (1.59e-7)"	"unprognostic (2.04e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.51e-1)"	14.5	18.4	21.3	13.6	17.6	19.9	17.2	12.2	19.8	16.7	15.8	17.7	12.3	13.6	14.7	32.2	25.0	11.0	16.3	34.6	20.2	21.6	14.6	24.1	12.9	26.4	23.4	10.1	10.4	62.8	16.3	13.2	22.2	24.2	14.9	19.6	11.4	15.3	18.2	32.1	10.3	17.9	20.2	20.2	14.6	15.1	13.9	16.8	15.8	32.9	17.4	17.7	18.7	16.4	10.9	23.1	35.6	30.0	39.9	29.1	24.6	13.7	7.9	18.1	18.5	23.6	28.8	25.6	13.0	18.6	14.7	15.1	8.6	8.8	7.1	4.7	29.0	11.7	20.5	28.2	22.9	10.8	8.0	9.8	10.0	27.9	29.7	4.1	23.1	16.5	46.6	19.3	29.5	25.9	29.8	4.6	26.5	20.6	11.1	18.0	19.9	12.0	13.5	12.0	12.7	22.1	5.8	12.1	18.1	15.2	11.5	23.9	10.4	17.1	16.1	16.2	14.2	18.3	13.9	5.7	4.4	13.9	19.2	12.5	11.9	35.6	21.0	25.2	29.1	27.6	11.5	10.9	19.9	17.6	18.6	10.1	18.6	18.8	15.6	39.9	30.0	23.1	20.5	24.6	21.3	17.6	12.2	19.8	20.2	21.6	23.4	10.1	24.2	16.8
UBE2H	"GID3, UBC8, UBCH"	ENSG00000186591	"Ubiquitin conjugating enzyme E2 H"	P62256	7	129830732-129952949	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003302	Approved		Supported	Mitochondria				Mitochondria		"HPA003302: AB_1858526"	"unprognostic (1.15e-1)"	"unprognostic (5.85e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavourable (2.33e-5)"	"unprognostic (1.13e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.23e-1)"	29.0	49.9	31.1	16.6	31.0	22.5	24.5	36.1	30.2	31.1	27.3	33.2	26.6	15.2	35.5	25.3	32.1	29.4	26.6	61.0	26.4	25.4	27.6	28.1	26.3	17.5	28.1	23.4	27.6	52.3	41.8	29.5	37.9	33.3	24.1	16.8	22.9	28.5	28.8	46.3	21.3	16.5	31.5	26.2	19.1	22.7	24.7	29.5	24.7	37.7	23.6	29.5	25.5	34.3	6.1	3.7	7.8	2.2	1.3	6.5	1.9	22.7	12.3	14.6	14.8	36.4	31.3	25.3	21.1	27.2	12.9	14.4	6.6	24.4	9.4	26.4	20.7	17.3	12.5	22.4	16.9	11.6	6.6	3.2	18.1	7.9	28.6	6.5	10.4	42.0	29.8	17.4	28.0	25.1	7.7	27.4	19.9	8.1	8.6	7.1	23.0	14.7	6.7	7.5	20.1	27.0	29.9	5.6	16.9	19.3	43.2	11.3	4.5	6.4	25.5	14.1	7.1	19.8	20.9	25.0	18.0	15.6	28.0	7.8	13.7	3.5	2.2	5.1	4.7	1.7	6.4	3.8	4.7	4.2	2.0	6.1	6.0	6.4	7.8	1.3	2.1	3.7	6.5	1.9	31.1	31.0	36.1	30.2	26.4	25.4	28.1	23.4	33.3	29.5
UBE2N	"MGC8489, UBC13, UbcH-ben"	ENSG00000177889	"Ubiquitin conjugating enzyme E2 N"	P61088	12	93405673-93442262	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA044976	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"			4600000	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044976: "	"unprognostic (1.74e-2)"	"unprognostic (5.53e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-2)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (8.49e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-3)"	24.7	25.0	29.0	28.7	39.1	29.0	21.2	29.2	44.3	18.4	26.6	15.6	15.1	20.7	23.2	20.0	30.4	19.7	17.0	27.7	31.0	33.7	25.4	22.3	19.3	36.1	27.6	34.5	17.4	17.6	13.9	18.2	24.2	34.9	23.4	22.6	13.7	18.0	18.5	35.7	19.1	20.4	21.3	24.6	21.5	19.3	83.7	17.4	32.2	15.5	16.8	35.1	22.7	18.8	53.8	35.5	29.9	39.2	29.5	57.3	51.9	35.8	26.0	43.9	28.1	17.0	16.9	30.6	50.2	26.8	40.3	33.8	46.2	15.6	73.0	11.4	29.3	28.6	48.4	36.8	38.4	60.7	25.1	49.1	14.3	40.7	21.7	58.6	32.8	17.7	15.2	24.0	30.0	31.0	54.5	11.4	41.8	29.5	57.8	54.5	57.1	36.4	45.0	35.6	35.7	33.5	54.3	42.9	39.1	26.5	31.2	24.5	40.8	36.1	32.0	27.3	22.8	24.6	36.1	19.7	53.3	62.0	10.7	31.3	33.3	29.9	27.1	28.9	31.7	35.4	36.9	53.8	40.2	39.2	35.5	38.6	36.0	34.4	8.2	29.5	39.2	26.7	57.3	51.9	29.0	39.1	29.2	44.3	31.0	33.7	27.6	34.5	34.9	17.4
UBE2L3	UBCH7	ENSG00000185651	"Ubiquitin conjugating enzyme E2 L3"	P68036	22	21549447-21624034	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA045609, HPA062415"	Approved		Approved	Nucleoplasm,Cytosol			8800000	"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: "	"unprognostic (4.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (9.99e-3)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.65e-2)"	"prognostic favourable (3.82e-6)"	"unprognostic (3.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.15e-3)"	27.8	34.9	34.8	23.5	29.6	31.3	24.9	25.5	36.9	25.9	27.7	38.4	22.8	26.4	25.6	29.2	38.0	26.9	23.0	33.0	30.7	30.8	27.4	36.0	23.5	32.5	34.3	33.1	24.3	23.9	24.3	21.7	30.1	36.9	27.5	31.7	29.3	30.6	26.7	43.5	23.9	34.4	33.1	36.2	28.5	25.1	35.7	22.6	25.3	25.0	32.4	33.9	28.4	22.2	34.7	49.9	46.1	45.8	34.6	46.9	54.9	24.4	14.1	20.7	16.1	22.6	20.2	11.9	20.6	23.6	26.6	25.3	16.0	11.8	23.1	10.4	27.3	21.0	27.5	22.4	26.5	23.0	29.7	26.7	13.8	19.1	15.1	38.1	19.3	17.8	19.6	19.2	14.0	29.8	107.9	12.4	28.6	18.0	19.8	27.6	15.2	14.9	16.2	31.1	6.3	24.9	19.7	18.6	13.8	16.4	20.7	18.9	12.9	21.1	21.3	18.8	24.2	15.9	21.0	12.1	19.5	21.1	25.5	17.7	17.8	30.8	40.4	46.1	41.4	45.8	38.8	34.7	39.6	44.2	49.9	31.2	34.5	41.6	34.2	34.6	37.6	48.4	46.9	54.9	34.8	29.6	25.5	36.9	30.7	30.8	34.3	33.1	36.9	22.6
UBE2B	"HHR6B, RAD6B, UBC2"	ENSG00000119048	"Ubiquitin conjugating enzyme E2 B"	P63146	5	134371179-134391992	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 83.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 83.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: , HPA051765: , HPA065898: "	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.39e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.52e-2)"	17.7	27.7	20.4	17.0	16.6	25.9	22.8	16.2	28.3	13.8	18.0	7.9	11.6	14.4	19.4	17.0	25.6	13.6	18.3	59.2	20.3	16.4	17.8	19.8	21.8	18.7	13.8	18.7	16.7	26.4	7.8	16.2	27.8	17.6	15.4	15.1	10.2	16.1	18.5	106.5	15.9	16.2	21.6	15.1	16.6	14.1	21.7	12.7	13.2	18.2	34.0	16.3	19.2	22.8	9.6	8.8	83.3	14.1	9.6	14.6	10.5	36.2	9.6	20.0	19.0	17.5	18.9	32.3	27.3	14.4	17.6	21.0	28.9	24.4	19.8	33.0	17.4	14.5	15.1	20.2	19.2	31.4	16.3	10.9	26.5	31.0	20.5	12.9	22.4	16.2	27.5	15.9	13.5	15.0	19.9	36.0	15.8	21.2	20.4	34.1	8.6	9.1	20.6	22.0	27.6	15.7	28.1	27.0	21.1	21.4	10.1	47.4	21.8	35.6	29.7	20.5	14.3	27.5	29.8	30.1	41.2	27.9	23.1	24.4	20.3	34.7	11.5	31.2	9.4	12.5	8.6	9.6	12.0	9.5	7.9	9.6	14.6	12.3	83.3	9.6	14.1	8.8	14.1	10.5	20.4	16.6	16.2	28.3	20.3	16.4	13.8	18.7	17.6	12.7
UBE2G2	UBC7	ENSG00000184787	"Ubiquitin conjugating enzyme E2 G2"	P60604	21	44768580-44802019	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003332	Approved									"HPA003332: AB_1858525"	"unprognostic (7.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.45e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.67e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.79e-3)"	"unprognostic (6.93e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.98e-3)"	"prognostic unfavourable (7.02e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.55e-2)"	30.9	20.7	18.9	22.8	20.9	25.8	21.1	21.0	21.6	18.9	22.7	20.5	19.8	14.9	22.2	18.4	19.3	20.5	18.0	37.1	18.3	17.1	26.2	27.3	19.7	19.7	19.0	17.0	18.1	30.2	22.1	26.0	17.0	18.9	18.3	16.5	18.6	15.4	28.3	50.8	15.6	16.9	28.5	17.8	23.8	20.2	14.0	18.8	18.4	20.6	18.7	21.6	20.9	18.9	11.9	17.5	5.9	13.0	14.0	17.3	12.1	15.6	3.2	10.8	13.9	14.8	6.5	9.9	11.1	8.6	9.7	10.6	12.4	2.1	20.3	10.6	11.0	6.3	15.8	13.4	8.8	19.0	16.3	33.0	2.3	10.0	11.7	24.3	5.7	10.4	15.9	13.0	12.7	15.2	30.6	14.2	13.3	7.0	26.9	2.9	28.1	14.0	22.1	10.0	18.1	12.7	8.4	12.6	22.4	15.6	5.1	16.0	4.9	21.2	10.8	9.4	6.7	8.7	17.9	22.3	43.8	20.1	9.4	28.8	11.0	2.3	11.6	5.9	16.0	11.8	17.3	11.8	14.7	16.2	12.5	11.9	15.7	16.6	3.6	14.0	13.0	17.5	14.6	12.1	18.9	20.9	21.0	19.3	18.3	17.1	19.0	17.0	18.9	18.8
UBE2J1	"CGI-76, HSPC153, NCUBE1, UBC6"	ENSG00000198833	"Ubiquitin conjugating enzyme E2 J1"	Q9Y385	6	89326625-89352848	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 62.5;Karpas-707: 54.0;U-266/70: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003509, CAB073419"	Enhanced									"CAB073419: , HPA003509: AB_1858531"	"unprognostic (1.82e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.55e-3)"	"prognostic favourable (2.87e-4)"	"unprognostic (3.41e-1)"	"unprognostic (7.93e-3)"	"prognostic unfavourable (6.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (9.36e-2)"	"prognostic favourable (7.43e-4)"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-2)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.87e-2)"	"unprognostic (9.38e-2)"	18.7	17.3	14.6	47.1	15.4	52.7	28.2	19.1	13.6	18.8	25.9	11.3	24.4	28.0	19.5	18.4	19.2	18.0	19.9	17.1	14.4	14.7	18.7	33.5	20.4	52.0	17.0	9.5	17.2	46.1	11.5	13.6	27.5	13.0	22.9	26.3	10.7	42.1	33.2	12.5	11.3	36.3	17.9	18.9	45.8	24.4	17.7	14.4	42.5	17.6	16.4	47.7	21.7	21.4	20.7	23.7	15.9	17.8	6.4	6.4	6.1	8.1	2.8	7.9	10.1	8.3	10.8	0.0	13.0	11.5	8.1	8.9	4.6	5.1	62.5	7.3	13.4	3.3	5.1	7.5	13.2	8.7	8.0	11.3	3.7	7.6	22.1	14.2	7.4	8.2	7.6	6.7	11.6	18.0	9.1	54.0	9.4	5.0	5.9	10.9	2.7	4.1	23.3	10.2	29.9	10.1	5.7	4.0	8.1	5.5	12.2	12.0	4.8	31.6	12.0	4.5	4.3	8.0	9.9	60.7	30.1	17.1	8.9	10.3	7.4	10.3	6.6	12.3	3.4	11.1	4.0	20.7	4.6	4.2	6.5	13.4	4.3	3.9	15.9	6.4	17.8	23.7	6.4	6.1	14.6	15.4	19.1	13.6	14.4	14.7	17.0	9.5	13.0	14.4
TMEM189-UBE2V1	"CROC-1B, Kua-UEV"	ENSG00000124208	"TMEM189-UBE2V1 readthrough"		20	50081124-50153637	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"HPA052535, HPA053186"			Supported	Nucleoplasm				Nucleoplasm		"HPA052535: , HPA053186: "	"unprognostic (3.69e-1)"	"unprognostic (1.27e-1)"			"unprognostic (2.41e-3)"	"unprognostic (2.71e-2)"		"unprognostic (1.52e-1)"	"unprognostic (6.05e-3)"					"unprognostic (2.40e-1)"			"unprognostic (8.19e-2)"	9.2	4.4	4.6	7.5	9.7	1.2	5.1	6.1	7.1	4.3	3.9	14.2	6.8	2.0	4.7	3.0	5.9	2.9	3.1	3.9	4.4	4.5	3.4	8.4	5.0	3.6	14.0	3.0	4.3	9.1	5.5	4.3	15.0	8.3	3.8	1.6	2.0	3.7	4.6	8.4	4.0	4.4	4.8	7.9	4.6	7.6	12.2	10.2	3.5	3.2	4.0	5.6	4.5	3.5	6.1	9.1	11.3	15.3	8.0	8.7	9.9	3.4	5.8	2.1	5.4	8.9	6.1	6.4	5.9	3.9	8.1	4.6	12.4	7.3	1.7	8.2	3.2	14.9	3.2	6.6	1.4	0.8	1.1	2.5	10.2	7.5	4.0	4.3	4.6	6.1	12.2	6.0	2.2	8.0	4.1	5.2	3.6	4.2	3.2	0.4	1.5	1.4	3.1	1.7	2.9	2.3	9.4	3.3	1.5	2.8	12.3	2.6	2.6	4.0	12.4	9.5	3.6	2.6	3.8	1.3	1.7	0.6	4.2	1.1	6.2	7.5	9.4	11.3	8.7	13.5	7.6	4.1	7.9	8.6	9.1	6.1	7.4	7.8	1.3	8.0	15.3	5.5	8.2	9.9	4.6	9.7	6.1	7.1	4.4	4.5	14.0	3.0	8.3	10.2
UBE2A	"HHR6A, RAD6A, UBC2"	ENSG00000077721	"Ubiquitin conjugating enzyme E2 A"	P49459	X	119574467-119591083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: , HPA051765: , HPA065898: "	"unprognostic (2.27e-3)"	"prognostic favourable (2.16e-4)"	"unprognostic (1.12e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (9.07e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.54e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (2.20e-6)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.92e-2)"	24.8	20.6	26.7	23.1	24.6	16.8	32.5	20.2	24.2	23.7	32.8	23.9	20.2	21.7	23.8	26.7	37.2	20.3	21.2	42.2	23.6	22.1	32.2	26.6	22.8	26.3	26.8	19.7	18.7	17.2	24.3	18.2	112.4	24.7	20.4	30.2	20.0	21.0	22.6	46.8	23.6	29.2	27.9	29.1	25.1	20.4	17.0	19.5	36.3	23.2	32.8	31.5	26.7	24.0	21.0	29.0	34.1	36.3	12.8	21.2	17.4	32.5	27.5	17.3	14.6	30.3	37.4	16.2	33.8	30.2	40.3	38.3	14.2	22.4	25.8	34.4	37.2	23.5	24.7	17.9	38.9	35.8	14.6	11.4	22.0	12.7	27.8	28.5	19.6	25.5	25.6	38.6	16.8	27.9	14.0	23.1	45.6	34.5	43.9	26.9	28.8	31.1	22.4	18.4	24.0	32.5	21.4	13.3	13.7	45.0	20.7	24.6	18.0	24.9	27.2	25.9	11.6	51.1	38.1	22.4	36.4	25.3	27.5	36.1	20.2	16.5	22.7	34.1	18.1	35.4	14.3	21.0	15.7	15.8	29.0	18.8	10.0	14.3	30.1	12.8	36.3	23.0	21.2	17.4	26.7	24.6	20.2	24.2	23.6	22.1	26.8	19.7	24.7	19.5
UBE2D2	"UBC4, UbcH5B"	ENSG00000131508	"Ubiquitin conjugating enzyme E2 D2"	P62837	5	139526431-139628433	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.14e-1)"	"unprognostic (2.75e-3)"	"prognostic favourable (5.09e-5)"	"prognostic favourable (5.90e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavourable (9.63e-7)"	"unprognostic (7.41e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavourable (2.09e-5)"	"unprognostic (8.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.07e-1)"	35.6	25.0	41.2	31.5	39.9	44.2	35.9	31.9	49.6	43.9	50.4	35.5	31.5	22.2	35.5	52.2	44.8	47.6	27.1	34.8	39.5	40.5	37.2	39.5	34.8	55.6	40.5	36.1	35.3	41.7	23.8	35.3	33.6	35.9	30.8	46.4	30.7	30.5	37.9	80.6	33.2	37.4	39.3	41.9	41.3	29.1	68.0	29.3	71.0	34.4	31.2	64.5	42.2	36.1	34.3	39.3	40.8	23.0	22.5	41.7	19.5	36.5	24.4	42.8	29.9	28.9	37.1	27.4	38.7	36.2	45.6	53.4	62.8	34.8	52.3	51.0	39.9	23.2	42.0	65.2	61.1	33.7	24.5	29.6	27.0	36.0	56.6	28.9	26.4	29.1	33.7	45.2	67.7	48.6	25.6	44.8	42.2	36.7	44.6	41.2	23.5	26.6	34.0	44.5	37.8	47.9	43.3	39.0	25.8	33.8	43.5	61.4	27.2	25.7	31.8	34.8	19.4	28.9	47.2	32.2	52.3	73.3	24.9	47.7	27.7	14.8	20.9	40.8	22.6	18.8	24.7	34.1	32.7	31.7	23.4	34.3	41.7	35.2	34.5	22.5	23.0	39.3	40.0	19.5	41.2	39.9	31.9	49.6	39.5	40.5	40.5	36.1	35.9	29.3
UBE2D3	UbcH5C	ENSG00000109332	"Ubiquitin conjugating enzyme E2 D3"	P61077	4	102794383-102868896	"Enzymes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003920	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (7.43e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.31e-2)"	"prognostic favourable (4.51e-4)"	"unprognostic (5.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.34e-2)"	67.2	70.6	39.1	52.7	44.6	132.7	70.4	36.9	50.9	45.5	51.8	37.5	38.4	49.3	46.3	39.1	63.2	45.7	47.5	72.5	37.3	39.5	63.0	91.9	67.5	68.1	43.4	36.9	60.6	53.4	42.8	49.1	66.5	45.2	49.6	48.5	38.4	46.7	43.3	91.1	53.2	58.9	48.4	44.4	68.2	49.5	40.0	42.2	88.8	66.3	55.4	61.4	74.6	81.4	24.7	31.2	118.0	36.2	29.7	33.2	50.9	52.5	30.1	50.3	40.6	53.7	77.6	43.3	53.6	71.4	47.8	45.2	45.2	75.1	56.4	35.1	54.3	30.2	53.6	71.9	65.9	52.3	27.0	51.3	31.0	36.8	56.4	72.1	44.2	58.9	45.6	52.7	73.9	62.0	64.4	57.6	63.6	42.5	105.7	41.1	36.4	30.2	55.8	49.4	40.7	48.2	50.3	50.8	42.8	32.9	84.5	60.4	35.1	42.7	56.9	50.1	42.9	32.8	48.6	51.1	65.8	86.2	53.4	40.2	53.7	71.1	35.9	54.6	25.1	36.1	33.2	24.7	31.8	29.6	31.2	20.1	32.6	29.7	118.0	29.7	36.2	21.5	32.6	50.9	39.1	44.6	36.9	50.9	37.3	39.5	43.4	36.9	45.2	42.2
UBE2I	UBC9	ENSG00000103275	"Ubiquitin conjugating enzyme E2 I"	P63279	16	1308880-1327018	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003909, CAB009021"	Approved						120000			"CAB009021: AB_2210610, HPA003909: AB_1858529"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (7.50e-4)"	"unprognostic (2.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.56e-1)"	"unprognostic (7.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.57e-1)"	"prognostic favourable (5.68e-4)"	"unprognostic (1.15e-3)"	34.3	43.1	28.8	36.3	36.9	48.4	45.2	45.6	48.5	38.1	32.0	28.6	28.1	28.9	55.4	32.9	43.4	35.6	30.3	41.8	27.4	28.4	29.4	26.6	29.1	44.2	22.7	32.9	62.5	35.5	33.4	36.2	47.2	21.4	40.7	31.0	34.1	37.8	32.2	31.6	35.8	32.2	40.0	23.2	43.7	29.4	43.6	21.6	78.0	42.5	31.8	53.9	38.7	38.8	82.2	58.0	85.4	67.4	50.9	57.8	60.0	24.9	34.5	58.2	34.3	25.0	30.3	25.2	36.0	26.0	33.5	33.5	40.8	41.1	43.5	30.0	31.1	30.5	41.6	33.8	43.3	31.3	29.4	27.2	31.9	39.4	39.6	40.3	32.5	28.0	22.0	32.8	39.3	36.2	38.9	27.4	31.6	53.3	71.2	40.6	47.4	25.5	90.4	36.9	49.5	31.2	23.0	33.0	34.8	31.6	35.9	35.9	36.5	48.9	29.8	33.3	38.2	29.2	32.5	29.0	34.3	88.8	18.7	30.0	35.2	63.9	59.3	85.4	48.0	67.4	57.8	82.2	49.0	48.7	58.0	61.8	44.1	44.2	41.3	50.9	62.3	50.1	50.9	60.0	28.8	36.9	45.6	48.5	27.4	28.4	22.7	32.9	21.4	21.6
UBE2R2	"CDC34B, FLJ20419, MGC10481, UBC3B"	ENSG00000107341	"Ubiquitin conjugating enzyme E2 R2"	Q712K3	9	33817567-33920404	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 21.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061000			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA061000: "	"unprognostic (1.51e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.15e-2)"	"prognostic unfavourable (4.37e-4)"	"unprognostic (1.82e-3)"	"unprognostic (4.61e-3)"	"unprognostic (3.05e-3)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.43e-1)"	26.1	19.7	29.4	19.7	26.8	13.9	39.3	23.7	32.3	25.6	24.1	27.9	16.3	28.0	26.1	18.4	25.3	22.3	21.8	29.2	25.5	20.3	22.1	34.5	23.0	27.1	30.5	23.2	29.8	44.5	15.7	13.9	24.6	21.6	21.0	21.4	19.3	18.7	20.8	56.1	28.1	25.7	28.5	24.2	21.6	20.8	34.5	29.6	36.7	19.5	22.5	25.7	35.8	30.5	3.3	4.2	21.9	11.6	5.0	2.1	2.4	16.3	18.0	34.6	15.0	19.1	31.2	10.6	14.6	20.3	17.1	17.1	14.4	12.3	14.0	6.0	20.3	7.3	18.1	16.6	18.8	23.0	9.6	12.0	19.8	18.3	27.2	14.3	13.1	26.4	24.7	14.0	26.5	28.7	11.3	15.1	16.9	9.5	26.9	37.6	19.7	14.9	25.0	10.5	7.2	18.1	12.4	16.2	19.5	17.0	15.2	10.9	13.4	17.4	21.4	16.5	15.0	11.4	13.5	9.6	9.0	19.5	15.8	8.3	35.5	12.4	7.5	4.1	2.0	7.5	1.3	3.1	1.9	1.6	4.2	3.3	1.9	1.7	21.9	5.0	11.6	2.6	2.1	2.4	29.4	26.8	23.7	32.3	25.5	20.3	30.5	23.2	21.6	29.6
UBE2W	"FLJ11011, UBC-16"	ENSG00000104343	"Ubiquitin conjugating enzyme E2 W"	Q96B02	8	73780097-73878910	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045161, HPA073181"	Uncertain		Approved	Nucleoli				Nucleoli		"HPA045161: AB_10960706, HPA073181: "	"unprognostic (5.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.17e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	15.2	14.2	13.5	13.3	21.8	17.5	13.4	18.9	24.4	12.0	9.8	11.3	11.0	7.9	13.4	10.5	16.6	9.4	15.2	14.8	19.0	12.3	21.9	23.4	13.6	11.6	11.6	13.0	11.8	12.7	18.4	20.9	13.6	18.4	12.0	11.5	9.5	12.2	10.6	16.4	10.6	8.5	12.8	12.6	13.6	10.0	16.4	12.3	14.7	17.1	4.8	12.9	16.8	12.8	5.0	8.1	23.0	9.4	4.7	4.3	4.8	8.5	5.6	6.9	7.5	12.1	12.4	6.0	9.4	10.4	9.1	9.5	4.6	9.6	4.0	7.8	9.8	8.7	10.2	9.6	15.2	6.4	6.2	8.1	5.8	7.1	8.2	4.4	11.5	9.7	10.8	10.6	19.0	11.0	4.0	8.6	13.8	6.8	9.6	4.8	5.3	11.1	2.9	7.1	3.4	16.9	9.4	5.1	5.6	7.5	24.5	11.3	11.5	7.9	9.8	11.0	8.4	8.3	6.9	7.3	7.5	2.9	9.6	7.1	9.4	12.9	9.4	11.5	3.5	8.8	4.3	5.0	3.6	2.6	6.3	4.3	3.2	3.8	23.0	4.7	9.4	8.1	4.0	4.8	13.5	21.8	18.9	24.4	19.0	12.3	11.6	13.0	18.4	12.3
UBE2L6	UBCH8	ENSG00000156587	"Ubiquitin conjugating enzyme E2 L6"	O14933	11	57551656-57568284	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003328, CAB073407"	Enhanced		Approved	Cytosol			34000	Cytosol		"CAB073407: , HPA003328: AB_1858539"	"prognostic favourable (6.75e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.37e-3)"	"prognostic unfavourable (4.88e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.42e-2)"	31.1	31.0	32.0	34.1	28.6	30.4	40.4	18.2	25.6	23.3	19.1	17.0	17.1	19.0	21.9	30.0	19.9	28.6	27.4	18.4	23.5	27.4	28.3	55.1	50.5	45.0	28.9	20.4	27.1	21.8	17.9	18.5	21.7	25.8	26.0	18.8	18.7	42.8	22.2	10.1	15.9	23.5	28.3	23.6	47.9	21.4	7.7	23.6	44.0	33.6	15.1	34.4	33.0	49.0	49.2	53.6	113.6	83.4	61.2	66.4	112.6	8.7	4.4	14.9	4.7	31.6	39.4	1.6	5.1	30.4	45.1	58.7	1.6	22.8	28.0	18.0	15.5	7.0	6.4	16.8	9.6	25.5	0.2	27.6	0.0	6.2	58.6	6.3	9.1	42.1	3.9	21.1	5.8	14.2	1.2	19.4	8.1	11.1	42.5	15.2	3.9	5.6	37.6	9.1	19.2	12.1	9.8	0.3	7.8	10.2	0.8	22.3	11.2	3.2	5.2	9.4	3.3	7.1	1.6	26.5	26.7	0.5	26.3	16.0	2.0	56.7	71.6	62.5	51.2	83.4	56.4	49.2	53.4	53.4	53.6	39.7	46.5	48.8	113.6	61.2	68.3	34.0	66.4	112.6	32.0	28.6	18.2	25.6	23.5	27.4	28.9	20.4	25.8	23.6
UBE2T	"FANCT, HSPC150"	ENSG00000077152	"Ubiquitin conjugating enzyme E2 T"	Q9NPD8	1	202331657-202341980	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002831			Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA002831: AB_1080445"	"unprognostic (2.38e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.27e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavourable (4.79e-6)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"prognostic favourable (6.90e-6)"	"unprognostic (6.28e-3)"	"unprognostic (2.85e-2)"	"prognostic unfavourable (2.22e-16)"	"unprognostic (5.37e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	1.9	4.2	9.6	8.5	12.2	20.8	3.9	4.4	13.5	3.5	11.2	0.7	17.2	7.5	4.3	4.1	10.3	2.9	3.0	8.8	8.8	11.2	4.5	2.8	3.1	15.2	8.7	8.2	1.3	0.9	2.4	3.1	8.7	8.2	2.2	13.9	1.9	2.8	7.0	13.1	4.5	6.9	8.1	3.4	6.7	4.0	16.0	1.8	46.8	2.6	12.8	15.3	6.3	4.5	9.0	3.6	1.7	8.6	1.1	11.1	2.9	30.3	29.0	43.2	20.4	4.0	7.4	24.7	33.2	18.6	38.0	26.8	20.6	37.3	35.4	13.2	12.1	24.8	39.9	19.5	34.3	32.1	22.8	21.6	15.8	23.5	1.8	25.9	26.4	2.6	4.7	29.9	12.4	22.0	27.3	29.3	29.7	28.3	46.3	33.0	16.7	14.8	35.9	46.0	30.8	14.5	14.6	34.0	34.7	23.2	28.6	11.1	30.1	16.4	10.8	17.1	27.4	29.9	39.4	14.9	29.0	45.1	17.0	27.0	35.5	0.0	0.8	1.7	3.7	2.4	2.8	9.0	5.0	3.9	1.7	6.3	7.3	8.0	0.0	1.1	8.6	3.6	11.1	2.9	9.6	12.2	4.4	13.5	8.8	11.2	8.7	8.2	8.2	1.8
UBE2U	MGC35130	ENSG00000177414	"Ubiquitin conjugating enzyme E2 U (putative)"	Q5VVX9	1	64203627-64267368	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	20	"testis: 31.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.3;U-266/84: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enhanced"	"Detected in many"		"midbrain: 19.5"															"unprognostic (9.44e-4)"				"unprognostic (5.52e-2)"		"unprognostic (1.81e-1)"	"unprognostic (2.37e-1)"		"unprognostic (4.01e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.69e-2)"			0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0
UBE2E3	UbcH9	ENSG00000170035	"Ubiquitin conjugating enzyme E2 E3"	Q969T4	2	180967248-181076585	"Enzymes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 113.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003303, HPA030445"	Approved									"HPA003303: AB_1858521, HPA030445: AB_10669599"	"unprognostic (8.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (8.08e-5)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (1.00e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.46e-2)"	"prognostic unfavourable (1.78e-5)"	"unprognostic (8.75e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.40e-1)"	29.1	23.9	35.6	21.1	33.0	20.1	49.7	37.4	62.9	30.4	25.2	18.6	19.8	23.0	26.6	29.2	23.1	29.7	35.9	37.8	43.9	32.5	36.0	29.6	28.5	37.6	31.5	31.9	27.7	29.9	42.9	21.6	23.9	30.5	20.9	27.8	24.6	26.3	22.7	76.8	28.1	26.2	24.1	41.3	20.4	28.3	28.1	21.5	30.9	37.4	27.8	23.0	31.8	23.0	7.7	29.7	25.6	16.9	8.5	12.0	9.6	17.2	7.9	113.1	3.9	33.6	43.4	18.0	23.2	29.4	19.6	24.5	8.5	21.1	8.5	20.4	31.6	7.4	68.2	23.8	35.3	20.8	20.6	29.5	10.7	23.6	16.2	13.6	14.1	17.1	22.2	17.1	16.6	25.8	15.0	16.0	48.1	9.5	24.8	12.8	21.6	37.4	24.3	11.5	20.3	33.3	15.3	19.7	22.0	10.1	10.7	9.5	5.8	20.2	23.7	38.2	25.2	22.3	27.0	14.0	8.9	24.0	37.7	5.4	21.1	13.0	14.0	25.6	9.3	12.3	11.1	7.7	7.3	12.0	9.2	4.9	7.8	8.5	13.2	8.5	16.9	29.7	2.8	9.6	35.6	33.0	37.4	62.9	43.9	32.5	31.5	31.9	30.5	21.5
UBE2K	"HIP2, HYPG, UBC1"	ENSG00000078140	"Ubiquitin conjugating enzyme E2 K"	P61086	4	39698044-39782792	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028869, CAB033212, CAB033515"	Supported		Supported	"Intermediate filaments,Actin filaments,Cytosol"			150000	Cytosol	"Intermediate filaments, Actin filaments"	"CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487"	"unprognostic (1.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (8.60e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.10e-3)"	27.2	21.8	27.0	21.2	27.6	17.3	21.6	38.6	40.7	17.0	33.2	11.8	14.1	29.1	19.9	18.5	29.9	14.9	18.5	28.1	27.7	26.8	26.6	44.5	17.1	17.9	24.1	26.4	16.9	15.8	18.9	26.9	29.8	25.2	19.7	24.0	13.4	18.4	17.3	31.8	22.0	24.6	18.8	19.2	16.9	29.3	16.0	15.9	21.3	23.6	19.7	18.8	22.8	20.4	17.6	23.7	20.6	19.9	10.9	14.1	8.9	23.8	24.5	13.2	12.5	8.3	7.8	22.5	32.9	7.0	8.8	9.3	37.0	24.6	29.8	29.0	9.2	10.1	25.4	14.3	14.2	20.0	18.2	38.6	24.8	32.0	10.4	41.4	21.9	7.3	16.2	12.4	13.4	11.5	39.2	10.7	9.1	23.1	28.9	23.0	17.6	18.7	17.1	39.7	11.2	12.3	33.3	27.4	12.1	24.6	9.3	14.7	12.0	13.9	31.5	13.8	29.3	16.4	30.2	15.2	44.3	32.8	7.2	26.6	16.1	13.9	16.6	20.6	13.5	14.3	12.7	17.6	14.1	12.6	16.6	12.5	10.7	12.0	13.3	10.9	19.9	23.7	13.7	8.9	27.0	27.6	38.6	37.7	27.7	26.8	24.1	26.4	25.2	15.9
UBE2Z	"FLJ13855, USE1"	ENSG00000159202	"Ubiquitin conjugating enzyme E2 Z"	Q9H832	17	48908369-48929056	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007922	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA007922: AB_1858551"	"unprognostic (6.85e-2)"	"unprognostic (5.72e-3)"	"prognostic favourable (4.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (2.32e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.17e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.52e-1)"	27.1	40.6	29.2	27.7	37.0	22.2	28.8	34.4	50.2	33.7	28.9	59.9	45.1	26.6	36.2	49.5	37.2	36.0	28.0	28.7	30.5	29.2	32.1	25.6	29.2	30.9	46.6	28.0	32.5	29.5	36.6	28.0	35.0	39.7	32.9	32.5	28.4	33.3	43.2	24.1	35.9	30.5	39.1	32.7	36.6	29.4	22.4	43.4	29.4	39.8	22.2	44.2	28.8	32.2	12.8	10.1	11.0	14.5	7.4	13.1	8.6	24.8	30.9	11.6	11.0	29.5	28.7	15.9	27.3	33.5	32.7	31.6	38.5	21.6	20.3	39.2	33.4	16.2	14.5	25.5	41.8	67.1	15.8	18.3	20.4	23.9	34.2	13.0	19.8	24.4	28.3	26.6	34.6	23.9	13.4	26.5	35.1	39.8	14.0	12.9	10.8	27.0	11.3	29.6	11.5	25.6	24.5	12.0	18.2	18.5	10.0	18.6	27.6	10.3	28.1	49.0	23.7	16.0	22.2	20.2	19.2	12.0	24.0	9.5	21.2	6.5	11.0	8.1	13.1	14.5	10.7	9.4	11.4	13.0	8.0	12.8	11.1	12.0	11.0	7.4	13.0	10.1	11.5	8.6	29.2	37.0	34.4	50.2	30.5	29.2	46.6	28.0	39.7	43.4
UBE2M	"hUbc12, UBC12"	ENSG00000130725	"Ubiquitin conjugating enzyme E2 M"	P61081	19	58555712-58558960	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004993, HPA054551, HPA057800"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.90e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.85e-2)"	"unprognostic (8.42e-3)"	18.1	26.0	51.8	16.3	38.9	32.1	13.6	28.4	52.4	15.2	20.4	17.0	20.5	17.8	17.3	19.6	24.9	19.3	17.4	43.2	35.1	33.9	19.6	19.1	16.5	18.1	32.1	30.5	19.4	20.2	25.9	22.8	32.0	26.4	18.4	16.7	15.0	20.9	22.6	61.9	19.2	15.9	19.2	19.8	18.5	17.9	31.8	16.1	32.7	22.2	21.2	19.9	18.2	23.5	3.8	7.6	10.9	4.3	1.8	3.8	2.1	21.1	38.6	19.6	18.6	10.5	12.5	14.3	22.1	19.5	16.0	13.8	23.3	16.5	22.3	16.7	15.6	13.9	21.7	21.8	12.0	25.3	131.9	32.4	24.8	15.1	25.6	29.3	25.7	13.3	17.1	24.4	29.0	19.2	15.7	28.2	21.2	21.7	23.3	26.6	12.4	33.8	21.8	16.3	28.6	18.4	26.7	34.4	28.2	19.1	23.4	20.6	14.1	26.9	14.4	50.2	10.2	15.7	39.1	34.1	51.6	23.9	31.9	26.0	32.7	6.8	4.3	4.1	3.5	2.8	2.7	3.4	3.8	3.7	3.1	3.8	3.7	2.5	10.9	1.8	2.7	7.6	3.1	2.1	51.8	38.9	28.4	52.4	35.1	33.9	32.1	30.5	26.4	16.1
CDC34	"E2-CDC34, UBC3, UBE2R1"	ENSG00000099804	"Cell division cycle 34"	P49427	19	531712-542092	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA002382, CAB005109, CAB047311"	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB005109: AB_2276050, CAB047311: , HPA002382: AB_1846370"	"unprognostic (4.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.73e-2)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.87e-3)"	"unprognostic (9.68e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.33e-2)"	16.5	15.9	21.3	11.3	19.1	24.7	20.4	25.7	30.9	16.0	20.5	19.5	10.5	15.4	13.3	13.4	15.6	14.5	13.6	35.6	21.1	18.2	12.1	36.0	13.0	9.9	18.5	19.8	17.0	37.4	11.3	17.0	24.9	16.2	17.2	10.6	15.3	26.4	18.5	63.9	19.0	13.2	18.6	14.3	12.7	15.7	43.6	15.0	12.2	13.1	17.0	8.7	19.2	16.4	2.9	2.8	11.5	4.5	1.5	4.1	1.3	18.4	18.4	23.7	19.5	10.8	10.3	23.7	16.6	12.7	17.9	18.7	28.6	11.3	10.2	17.4	11.8	12.8	18.6	14.0	9.2	16.6	50.0	9.4	12.2	30.9	26.9	13.2	11.4	13.3	21.0	15.1	15.8	21.3	40.2	20.4	11.8	26.4	18.0	17.6	29.9	17.9	16.7	12.2	17.1	13.5	11.0	30.9	22.9	14.4	15.0	27.6	12.0	19.4	17.4	13.1	15.6	30.4	22.1	20.4	15.6	13.6	17.9	18.7	13.5	4.5	3.5	6.2	2.3	3.4	1.7	2.9	3.2	4.1	2.8	1.7	2.5	2.4	11.5	1.5	4.5	2.3	3.1	1.3	21.3	19.1	25.7	30.9	21.1	18.2	18.5	19.8	16.2	15.0
UBE3B		ENSG00000151148	"Ubiquitin protein ligase E3B"	Q7Z3V4	12	109477402-109536705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041012	Approved		Approved	"Nuclear speckles,Mitochondria"				"Nuclear speckles"	Mitochondria	"HPA041012: AB_10964435"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.37e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.23e-1)"	"prognostic favourable (2.49e-5)"	"unprognostic (3.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	14.5	19.3	17.2	12.9	21.2	9.2	15.3	19.7	27.8	14.4	17.3	23.3	14.0	14.6	17.4	16.2	20.1	19.3	13.9	28.6	14.6	11.6	19.8	16.4	15.5	13.1	18.6	13.9	18.4	20.3	25.5	15.1	16.8	15.8	17.5	21.2	20.7	15.7	17.4	34.0	21.6	16.3	18.6	15.2	17.0	17.3	24.5	18.3	18.2	21.1	17.6	15.9	19.5	19.6	15.9	14.5	22.4	16.7	14.3	18.2	11.4	10.4	16.6	13.0	9.4	22.2	17.9	11.4	13.8	15.9	16.8	11.3	17.3	10.8	6.5	10.3	22.6	13.5	13.2	17.7	16.3	14.3	9.3	12.5	10.8	15.6	14.3	10.1	10.5	20.3	16.6	16.3	19.6	18.1	13.6	6.2	19.1	16.4	6.9	14.8	13.3	20.0	11.5	12.3	12.8	14.4	18.9	12.1	22.4	16.1	22.0	10.8	22.4	10.8	16.5	20.9	6.0	10.6	9.8	13.9	11.5	11.5	20.8	8.5	17.3	22.4	15.3	14.3	15.9	16.7	15.7	15.9	15.3	11.2	14.5	12.9	12.9	17.1	19.5	14.3	13.6	13.5	18.2	11.4	17.2	21.2	19.7	27.8	14.6	11.6	18.6	13.9	15.8	18.3
ITCH	AIP4	ENSG00000078747	"Itchy E3 ubiquitin protein ligase"	Q96J02	20	34363235-34511393	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021126, HPA049032, CAB072824, CAB072825"	Supported		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: "	"unprognostic (2.51e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.21e-1)"	20.7	16.7	18.9	15.4	26.9	20.5	17.5	19.8	26.7	23.9	18.2	37.9	15.2	16.9	18.4	15.1	35.9	14.5	14.5	17.9	20.4	15.9	21.1	46.5	18.5	16.8	29.2	16.5	19.3	17.1	21.6	26.3	26.9	29.0	17.5	20.4	16.7	20.1	18.4	24.0	19.2	20.3	19.8	30.4	17.3	17.3	34.8	32.3	22.3	22.7	13.0	23.6	19.6	21.0	7.3	11.4	19.6	6.2	6.2	11.4	2.7	20.0	13.2	13.5	9.7	14.9	21.3	16.2	16.3	18.7	20.4	20.0	37.2	30.9	9.8	15.8	20.8	25.4	20.5	32.9	24.9	7.4	6.6	28.4	11.2	22.2	15.6	11.6	12.9	10.8	16.8	17.2	27.0	15.3	16.1	17.0	15.9	10.0	17.0	6.2	6.5	15.7	14.3	28.5	22.6	12.1	34.8	8.3	6.1	30.5	11.9	18.3	14.3	10.5	14.8	24.4	14.7	15.9	12.0	13.5	14.1	14.3	15.1	7.5	14.3	3.6	5.8	6.1	10.8	6.2	11.4	7.3	3.8	5.7	4.5	6.9	3.3	4.9	19.6	6.2	3.8	11.4	4.8	2.7	18.9	26.9	19.8	26.7	20.4	15.9	29.2	16.5	29.0	32.3
NEDD4L	"KIAA0439, NEDD4-2, RSP5"	ENSG00000049759	"Neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase"	Q96PU5	18	58044367-58401540	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 50.1;SK-MEL-30: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 8.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.7;T-cells: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024618	Approved									"HPA024618: AB_1854362"	"unprognostic (2.56e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.26e-2)"	"unprognostic (9.24e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (6.55e-15)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (4.75e-2)"	5.9	6.8	9.1	5.4	38.8	13.2	15.8	21.4	24.7	5.0	22.6	3.2	18.2	11.1	3.6	6.1	7.0	6.0	7.6	12.7	9.8	7.1	29.9	10.1	26.9	2.5	7.2	14.9	3.0	33.2	9.2	16.5	13.0	4.1	30.6	25.2	12.2	16.5	23.2	38.3	5.9	26.8	8.2	3.2	3.1	26.0	4.6	8.8	0.8	9.1	5.5	5.1	14.9	9.3	1.4	0.4	4.7	0.7	0.9	8.1	0.5	18.4	6.6	3.9	5.8	1.4	0.5	13.6	5.2	23.7	13.4	20.5	7.7	10.0	3.9	16.1	2.0	13.4	5.2	23.1	27.7	9.2	4.6	2.8	4.1	50.1	0.7	0.1	1.7	3.5	15.1	18.1	22.0	1.0	4.8	1.7	5.5	4.5	0.2	0.2	3.4	10.2	3.8	5.3	4.5	13.3	24.1	4.9	1.3	4.3	1.3	39.1	7.9	1.6	7.9	36.2	10.9	2.0	22.3	2.3	3.9	2.4	7.4	2.8	2.9	4.7	0.6	1.7	0.4	0.7	1.0	1.4	1.3	0.3	0.3	0.6	0.8	0.6	0.3	0.9	0.1	0.4	8.1	0.5	9.1	38.8	21.4	24.7	9.8	7.1	7.2	14.9	4.1	8.8
PJA1	"FLJ11830, RNF70"	ENSG00000181191	"Praja ring finger ubiquitin ligase 1"	Q8NG27	X	69160851-69165793	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 98.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000595	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA000595: AB_1079826"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (7.44e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-1)"	12.6	9.9	21.6	5.5	35.7	2.6	7.9	13.4	23.7	12.2	5.8	8.9	19.3	4.7	9.2	98.7	5.7	10.2	7.1	7.5	18.4	23.4	7.5	4.4	7.4	5.9	14.9	16.7	16.2	6.0	27.1	12.5	10.7	11.7	9.9	5.3	7.2	6.4	20.3	4.7	7.1	4.4	9.8	12.0	5.9	6.5	13.7	9.5	3.0	13.8	2.9	7.4	7.8	7.9	11.2	4.3	2.7	4.5	14.8	17.8	9.0	10.4	8.0	25.1	17.5	8.8	9.3	7.5	7.0	8.4	6.6	8.9	6.5	9.9	1.6	10.9	11.0	9.1	38.5	13.6	8.3	7.8	13.7	3.1	6.6	4.3	11.0	1.8	6.0	9.7	9.1	11.2	6.7	7.4	2.9	1.1	6.7	5.6	0.8	3.5	17.1	13.1	7.5	11.2	2.5	10.6	8.8	18.6	12.1	11.2	1.9	8.5	3.1	2.6	6.7	5.7	9.2	16.9	3.2	0.0	0.1	3.8	6.2	5.1	7.6	2.7	3.3	1.0	15.5	4.5	17.8	8.7	13.7	14.2	3.6	11.2	14.4	16.6	1.1	14.8	2.9	4.3	8.3	9.0	21.6	35.7	13.4	23.7	18.4	23.4	14.9	16.7	11.7	9.5
RNF8	KIAA0646	ENSG00000112130	"Ring finger protein 8"	O76064	6	37353972-37394738	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA050731, HPA064925"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA050731: , HPA064925: "	"unprognostic (1.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavourable (3.33e-5)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (1.91e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavourable (4.99e-5)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.09e-1)"	8.0	11.7	13.1	8.2	17.8	8.9	11.5	25.7	18.7	9.2	9.5	10.6	6.8	6.9	13.5	5.7	18.3	12.0	8.8	17.6	13.4	14.8	11.8	7.5	10.8	8.3	12.0	16.0	13.2	6.5	11.9	16.4	10.2	13.7	8.6	8.2	8.0	10.2	11.9	15.2	9.9	8.4	10.7	9.6	7.7	7.6	19.8	13.8	6.6	8.0	9.4	13.3	12.9	15.2	8.8	8.3	2.6	8.1	7.6	10.8	5.5	6.5	3.9	9.5	11.3	7.7	11.1	2.7	6.8	8.4	12.9	14.2	5.8	3.7	8.1	4.2	6.6	6.2	13.2	8.6	13.6	8.5	12.8	14.0	6.9	8.7	4.4	7.4	10.3	5.5	8.3	7.7	9.0	12.4	9.4	2.8	7.4	4.3	9.0	9.2	6.6	5.2	7.1	8.8	5.6	6.6	4.6	18.8	6.3	5.1	5.8	9.4	5.2	7.3	5.6	8.5	7.6	8.0	10.0	8.4	11.1	40.0	4.2	10.6	9.8	1.0	4.6	2.6	10.8	6.0	10.0	8.8	8.1	10.2	8.3	6.0	7.1	9.4	0.6	7.6	8.1	3.6	9.3	5.5	13.1	17.8	25.7	18.7	13.4	14.8	12.0	16.0	13.7	13.8
CBLB	"Cbl-b, RNF56"	ENSG00000114423	"Cbl proto-oncogene B"	Q13191	3	105655461-105869552	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018327, HPA019880"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA018327: AB_1846097, HPA019880: AB_1846099"	"unprognostic (2.65e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.89e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.09e-2)"	38.4	9.0	3.7	19.5	4.9	15.5	16.3	24.4	3.8	13.7	18.7	5.9	7.7	9.3	13.8	12.2	8.3	12.5	13.4	27.5	3.8	4.8	7.4	6.7	16.3	19.1	4.4	1.9	17.7	6.8	3.4	13.5	25.4	7.9	12.9	8.0	11.6	9.1	6.3	10.3	8.5	13.8	25.6	5.7	16.4	12.4	9.2	5.2	11.6	13.5	7.0	18.0	24.9	24.1	5.1	3.1	2.8	2.1	10.3	9.9	1.6	1.6	2.2	7.6	3.7	8.7	8.8	4.9	5.6	2.8	1.6	2.7	2.9	1.9	3.6	4.0	3.0	2.8	1.0	1.0	2.0	2.7	2.9	1.9	11.7	1.8	12.8	1.3	1.4	8.4	3.0	4.4	12.0	5.5	2.0	11.5	3.5	2.0	1.9	0.9	2.7	3.2	4.1	2.3	0.6	4.0	7.2	5.8	6.4	6.7	0.8	8.8	1.6	2.9	3.1	23.4	2.0	3.2	1.3	6.5	0.5	5.6	6.2	1.2	1.5	0.7	1.5	2.8	9.9	0.9	8.8	2.2	5.1	5.6	1.3	5.1	4.4	8.0	1.0	10.3	2.1	3.1	5.6	1.6	3.7	4.9	24.4	3.8	3.8	4.8	4.4	1.9	7.9	5.2
DBT		ENSG00000137992	"Dihydrolipoamide branched chain transacylase E2"	P11182	1	100186919-100249834	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026481, HPA026485, HPA026533"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.90e-1)"	"prognostic favourable (8.79e-12)"	"unprognostic (1.63e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.67e-2)"	"unprognostic (9.92e-2)"	8.6	14.1	8.3	5.0	13.6	3.9	8.7	8.0	11.8	8.5	7.8	7.9	13.6	6.6	9.8	6.6	13.6	8.6	5.2	18.1	8.6	7.3	22.2	29.1	8.0	5.3	10.2	8.2	9.1	13.7	10.2	12.3	7.3	9.4	12.0	7.6	5.2	11.3	8.3	15.7	8.1	5.8	11.2	8.6	6.0	12.6	5.7	8.2	9.6	13.0	8.7	6.3	12.8	7.7	4.4	2.6	3.3	3.1	4.0	5.0	2.1	11.5	5.7	5.2	10.6	11.6	10.1	12.2	7.9	6.4	7.1	8.6	11.8	4.4	10.5	11.6	4.7	10.4	11.6	8.4	8.9	11.1	6.7	7.6	10.9	5.8	9.9	10.0	3.6	9.8	9.3	5.8	9.1	6.6	12.2	11.5	5.6	2.6	8.3	3.2	11.0	11.4	8.1	19.2	7.9	7.8	10.5	9.2	5.7	17.5	15.6	13.2	12.3	6.2	7.6	7.0	4.7	8.9	7.1	8.1	8.2	5.4	8.3	6.2	3.1	3.3	2.2	1.8	4.9	3.1	5.0	4.4	4.4	4.2	2.2	4.1	4.5	4.2	2.1	4.0	2.7	2.6	3.4	2.1	8.3	13.6	8.0	11.8	8.6	7.3	10.2	8.2	9.4	8.2
HECTD3	FLJ21156	ENSG00000126107	"HECT domain E3 ubiquitin protein ligase 3"	Q5T447	1	45002540-45011329	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027467	Approved						34000			"HPA027467: AB_10600710"	"unprognostic (1.86e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (2.14e-5)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.35e-1)"	"prognostic favourable (1.85e-6)"	"unprognostic (3.19e-1)"	18.4	16.9	9.6	16.7	11.1	9.2	25.9	12.4	14.8	11.2	38.0	14.8	11.7	34.1	12.4	12.4	16.7	9.1	14.6	8.7	9.9	8.4	16.4	22.9	10.5	11.3	10.9	7.9	14.1	24.1	22.9	8.0	11.8	10.8	10.4	19.5	9.7	27.0	15.4	24.2	20.1	59.3	12.0	9.9	14.0	13.9	11.7	9.7	11.9	13.3	14.8	12.5	13.8	12.0	8.7	9.9	10.4	15.1	5.0	10.9	7.5	11.2	10.2	6.5	10.6	23.1	14.5	13.0	10.8	16.4	11.9	13.5	14.5	3.5	5.3	9.2	17.6	10.5	15.5	11.2	10.7	9.8	12.0	8.5	14.9	12.7	20.2	6.6	14.3	15.6	19.2	20.3	7.9	26.5	18.9	6.0	15.1	9.6	8.3	5.4	9.0	15.6	9.9	11.8	7.6	17.5	13.3	15.8	6.6	14.5	25.2	12.8	8.2	6.2	19.8	13.8	11.0	17.1	12.2	7.7	9.0	2.9	22.1	7.2	6.7	9.4	10.4	10.4	10.9	15.1	9.1	8.7	8.9	9.3	9.9	5.1	7.5	8.9	4.0	5.0	8.2	7.5	9.0	7.5	9.6	11.1	12.4	14.8	9.9	8.4	10.9	7.9	10.8	9.7
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favourable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	16.9	14.9	22.0	18.8	24.8	22.2	18.4	33.5	27.8	17.8	26.9	22.0	13.4	11.5	26.9	13.3	18.7	19.6	14.2	29.1	20.5	17.4	12.7	11.8	14.9	23.8	23.8	14.8	25.6	21.3	23.2	24.9	14.6	20.4	17.7	11.8	18.9	16.2	21.5	22.5	15.1	20.1	25.0	18.7	23.3	18.3	34.3	26.3	18.5	19.8	9.6	24.1	17.7	30.7	8.8	6.7	24.5	8.4	10.0	9.7	6.5	14.4	15.6	12.8	21.8	15.3	13.3	8.8	15.5	16.3	16.1	14.9	11.3	8.3	12.7	8.0	17.3	10.4	13.3	10.9	13.2	7.9	11.6	9.8	9.5	11.4	18.4	16.0	16.8	13.7	14.0	12.3	15.1	12.7	19.6	8.9	17.8	22.2	6.0	25.5	17.6	13.0	15.3	18.1	7.1	9.6	12.2	9.8	15.6	9.8	24.6	8.8	9.7	16.4	13.8	16.3	29.4	16.6	13.9	7.2	5.4	10.3	12.2	14.9	25.9	1.3	7.7	24.5	9.0	8.4	9.0	7.3	7.9	6.7	6.7	8.8	9.7	9.1	13.1	10.0	7.7	5.4	7.0	6.5	22.0	24.8	33.5	27.8	20.5	17.4	23.8	14.8	20.4	26.3
UBA6	"FLJ10808, UBE1L2"	ENSG00000033178	"Ubiquitin like modifier activating enzyme 6"	A0AVT1	4	67612652-67701179	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037001	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA037001: AB_10672787"	"unprognostic (2.52e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.30e-2)"	"prognostic unfavourable (7.01e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.05e-3)"	16.8	12.6	14.1	14.1	16.6	22.7	13.0	18.0	16.0	17.0	10.5	14.6	7.0	12.2	16.7	10.0	20.5	9.9	12.4	9.5	12.0	12.0	10.2	16.4	14.5	17.3	18.7	11.2	14.3	10.9	17.4	44.8	18.5	17.7	12.7	13.2	7.5	13.7	10.4	10.1	12.6	15.3	13.4	20.7	16.9	13.9	14.6	18.6	27.1	12.3	13.3	19.9	15.7	19.5	5.6	5.1	9.3	4.0	9.7	5.8	1.9	14.8	8.3	13.8	10.8	6.8	8.1	9.3	30.8	12.1	14.1	16.5	8.7	20.1	18.8	11.0	12.6	8.8	14.2	15.3	21.3	21.6	4.0	12.0	14.7	8.1	5.8	21.1	9.2	5.7	4.9	18.2	11.1	12.4	28.6	11.2	16.6	5.6	21.9	4.8	8.1	10.1	13.0	28.3	6.9	11.5	16.9	6.7	8.5	17.4	12.4	5.8	8.2	5.7	17.9	13.1	14.7	10.6	13.4	8.1	6.3	19.0	23.3	5.9	12.5	9.3	3.0	4.6	4.4	3.9	4.8	5.6	5.1	5.8	3.7	5.2	3.9	4.5	2.2	9.7	4.0	5.1	4.2	1.9	14.1	16.6	18.0	16.0	12.0	12.0	18.7	11.2	17.7	18.6
UBOX5	"KIAA0860, RNF37, Ubce7ip5, UIP5"	ENSG00000185019	"U-box domain containing 5"	O94941	20	3107573-3160196	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028871	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA028871: AB_10603140"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"prognostic favourable (4.52e-5)"	"unprognostic (2.58e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.61e-1)"	"prognostic favourable (1.80e-5)"	"unprognostic (4.02e-2)"	"unprognostic (9.71e-3)"	"unprognostic (3.33e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.61e-2)"	10.1	9.9	9.6	10.0	13.0	17.7	15.4	14.9	16.3	11.6	12.7	12.3	9.0	8.6	14.1	8.8	11.2	13.9	8.8	10.8	10.0	9.1	13.7	12.2	10.1	19.6	10.0	10.2	15.2	17.8	12.8	11.6	11.1	11.9	11.8	8.8	9.5	13.2	13.6	34.1	16.3	10.7	12.2	7.9	10.4	10.8	15.1	9.3	14.9	10.4	11.1	11.5	12.8	9.7	8.7	7.0	11.4	7.0	7.5	8.4	5.5	6.2	6.4	5.1	3.3	6.7	3.7	2.7	5.3	4.8	6.4	6.4	6.0	5.4	4.7	2.0	4.4	8.7	3.4	7.9	3.9	1.4	2.9	8.2	1.9	5.5	5.4	3.4	3.3	4.8	5.9	5.2	6.5	4.1	6.7	4.7	3.7	4.2	7.0	5.2	4.0	3.9	4.7	6.4	3.4	4.0	6.4	6.3	6.0	3.3	19.6	4.1	8.4	2.6	4.6	4.3	2.8	4.7	4.3	6.2	9.1	4.2	2.4	3.6	3.1	11.1	7.0	11.4	7.1	7.0	7.3	8.7	8.0	5.8	7.0	6.8	8.4	8.1	11.4	7.5	5.9	5.6	7.6	5.5	9.6	13.0	14.9	16.3	10.0	9.1	10.0	10.2	11.9	9.3
CBL	"c-Cbl, CBL2, RNF55"	ENSG00000110395	"Cbl proto-oncogene"	P22681	11	119206276-119313926	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004350, HPA027956"	Enhanced		Supported	Cytosol				Cytosol		"CAB004350: AB_2244054, HPA027956: AB_10601094"	"unprognostic (2.52e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.10e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	9.9	5.5	9.1	17.0	11.1	11.1	8.8	10.7	12.0	6.2	7.5	8.7	3.0	5.7	9.9	5.3	7.5	7.4	6.3	5.9	8.0	9.6	5.5	4.0	10.3	16.3	8.1	6.9	6.3	5.6	16.6	4.1	9.1	9.3	5.3	7.5	6.4	5.4	7.1	3.9	7.4	8.6	10.6	8.9	13.3	7.3	32.3	5.1	40.9	6.0	5.5	15.6	7.6	7.7	1.8	3.3	11.8	3.7	0.6	1.9	1.0	6.3	4.8	16.8	10.5	5.0	6.0	9.9	6.8	7.1	6.6	6.6	10.2	7.8	15.0	6.2	8.6	9.3	11.5	5.8	14.5	8.5	2.7	15.4	3.6	3.1	6.2	17.9	17.6	5.2	6.5	16.9	18.2	16.3	12.4	6.3	11.9	6.8	9.5	10.0	8.7	5.3	10.3	8.4	2.8	5.9	5.1	2.3	7.0	12.7	5.5	4.5	5.8	15.1	13.6	10.3	7.3	7.2	8.9	2.1	3.1	12.2	4.2	15.5	7.3	0.8	3.2	2.4	1.3	3.7	1.1	1.8	1.6	1.3	3.3	1.8	1.8	1.9	11.8	0.6	3.1	1.8	1.4	1.0	9.1	11.1	10.7	12.0	8.0	9.6	8.1	6.9	9.3	5.1
TMEM189	Kua	ENSG00000240849	"Transmembrane protein 189"	A5PLL7	20	50118254-50153734	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059549	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA059549: "	"unprognostic (3.11e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (7.51e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.79e-2)"	"prognostic unfavourable (5.79e-11)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.42e-2)"	15.1	13.9	12.0	11.0	23.8	7.7	13.6	7.9	18.1	13.0	14.5	33.7	20.5	13.2	16.3	17.3	27.0	10.0	12.3	15.5	15.0	10.7	9.1	21.0	14.3	8.3	33.1	9.0	6.5	8.9	19.8	6.5	26.1	20.7	13.3	11.5	7.9	14.6	22.0	17.1	24.3	13.2	32.2	32.1	10.4	14.5	11.3	24.9	10.0	8.5	11.7	14.8	16.0	15.4	2.0	6.2	6.3	13.9	4.1	5.8	3.9	8.7	8.0	9.6	7.5	14.7	11.1	16.1	6.1	5.8	13.0	7.3	21.7	14.0	3.2	9.9	5.8	24.3	4.8	12.5	4.7	1.7	3.7	4.1	11.7	18.5	8.3	6.7	11.3	9.3	29.2	7.3	7.7	15.4	4.3	4.8	4.3	7.7	5.3	16.9	4.7	8.4	4.3	7.4	3.5	24.4	12.9	5.0	3.3	7.0	24.2	13.8	3.8	9.5	12.2	11.0	5.7	7.0	6.0	3.5	5.8	1.3	9.4	5.0	8.8	5.3	5.7	6.3	3.7	10.8	2.9	2.0	4.1	3.1	6.2	1.9	3.5	4.1	2.3	4.1	13.9	3.9	5.8	3.9	12.0	23.8	7.9	18.1	15.0	10.7	33.1	9.0	20.7	24.9
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719481-108785811	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Enhanced	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"		"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: , HPA049497: , HPA051675: , HPA067564: "	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.5	24.3	14.4	17.0	18.6	35.5	24.4	23.1	22.2	19.8	17.1	12.8	25.5	13.3	19.9	21.5	17.0	19.1	14.8	20.2	12.9	12.5	18.9	19.5	17.7	19.2	15.1	17.0	32.4	24.1	48.5	37.5	18.8	16.5	21.8	15.8	14.3	20.0	31.6	37.5	17.3	17.4	23.2	17.8	16.3	20.9	20.6	15.9	26.6	28.7	18.0	17.5	20.5	19.7	5.6	5.1	8.3	6.3	4.2	8.7	2.3	18.2	11.2	16.1	14.6	18.8	16.9	15.6	16.5	13.1	13.6	12.0	27.8	8.8	28.8	12.8	17.1	15.4	27.5	17.1	19.9	17.5	13.3	30.0	13.9	19.6	11.0	35.0	10.1	14.1	13.1	21.3	16.6	20.8	32.1	16.0	18.0	10.1	15.5	14.3	20.3	13.4	14.6	24.8	13.9	12.1	22.9	23.5	10.8	14.6	12.6	16.0	8.0	16.1	24.8	14.3	18.9	10.0	18.4	13.3	19.6	26.2	11.1	15.8	11.0	8.3	5.3	5.1	7.6	3.4	8.7	5.5	6.3	6.9	4.2	5.6	6.2	6.7	8.3	4.2	6.3	5.1	5.1	2.3	14.4	18.6	23.1	22.2	12.9	12.5	15.1	17.0	16.5	15.9
